MENINGIOMA GENOMIC SUBGROUP AS A PREDICTOR OF POST-OPERATIVE PATIENT OUTCOMES: IMPLICATIONS FOR TREATMENT AND FOLLOW-UP

Sadeleştirilmiş öğe sayfası
dc.contributor.authorYoungblood, Mark
dc.contributor.authorSheth, Amar
dc.contributor.authorZhao, Amy
dc.contributor.authorMontejo, Julio
dc.contributor.authorDuran, Daniel
dc.contributor.authorLi, Chang
dc.contributor.authorTyrtova, Evgeniya
dc.contributor.authorOzduman, Koray
dc.contributor.authorPeyre, Matthieu
dc.contributor.authorBoetto, Julien
dc.contributor.authorOmay, Sacit
dc.contributor.authorKalamarides, Michel
dc.contributor.authorErson\\-Omay, E. Zeynep
dc.contributor.authorGunel, Murat
dc.contributor.authorMoliterno, Jennifer
dc.date.accessioned2025-10-16T15:22:27Z
dc.date.issued2019
dc.description.abstract24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS, Phoenix, AZ, NOV 20-24, 2019
dc.identifier.otherWOS:000509478702122
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7837
dc.publisherOXFORD UNIV PRESS INC
dc.sourceNEURO-ONCOLOGY
dc.titleMENINGIOMA GENOMIC SUBGROUP AS A PREDICTOR OF POST-OPERATIVE PATIENT OUTCOMES: IMPLICATIONS FOR TREATMENT AND FOLLOW-UP
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS